-transparent.png){kind=logo}
Quantitation of myeloperoxidase (MPO) activity by guaiacol peroxidation (GP) assay is profoundly affected by the peroxidase present in eosinophils (EPO) that contaminate the granulocyte suspensions. Inclusion of 3-amino-1,2,4-triazole (AMT) in the GP assay permits quantitation of MPO activity in mixed neutrophil-eosinophil suspension because of the differential inhibition of EPO and MPO by AMT. Results show that: (1) the peroxidase activity of eosinophil-free granulocyte suspensions is not appreciably affected by AMT; (2) in the presence of AMT the peroxidase activities of granulocyte preparations containing different numbers of eosinophils are similar on a neutrophil basis, regardless of the number of eosinophils and correspond with the activity of eosinophil-free granulocyte suspensions; (3) AMT almost completely inhibits the activity of partially purified EPO, only slightly affecting the catalytic activity of partially purified MPO; (4) AMT completely inhibits the residual peroxidase activity of granulocyte suspensions from MPO-deficient subjects contributed by contaminating eosinophils. The GP assay in the presence of AMT was used to study the pattern of hereditary transmission of MPO deficiency. The genealogy derived on the basis of this assay was compatible with an autosomal recessive inheritance, in agreement with previously reported results, while no definite pattern of inheritance could be established by use of the GP assay without AMT. We suggest that the GP assay supplemented with AMT is the method of choice for detection of MPO deficiency, particularly partial deficiency.
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
January 1998,
Annales de biologie clinique,
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
February 1979,
The Journal of laboratory and clinical medicine,
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
January 1984,
Nouvelle revue francaise d'hematologie,
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
March 1991,
Journal of immunological methods,
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
January 1979,
Journal of immunological methods,
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
April 1975,
Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
October 1994,
International archives of allergy and immunology,
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
April 2016,
Monoclonal antibodies in immunodiagnosis and immunotherapy,
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
October 1995,
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
R Cramer, and
M R Soranzo, and
P Dri, and
R Menegazzi, and
A Pitotti, and
G Zabucchi, and
P Patriarca
September 2007,
Journal of biomolecular screening,
